S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George Thomas Budd, MD
The Cleveland Clinic
Study Chair - Halle C Moore, MD
The Cleveland Clinic
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
542 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Care Program at Thunder Bay Regional Health Sciences
Thunder Bay, Ontario, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- San Juan City Hospital
San Juan, Puerto Rico
- Regional Medical Center
Anniston, Alabama, United States
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
- Providence Cancer Center
Anchorage, Alaska, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants - Castro Valley
Castro Valley, California, United States
- Valley Medical Oncology
Fremont, California, United States
- California Cancer Center - Woodward Park Office
Fresno, California, United States
- Todd Cancer Institute at Long Beach Memorial Medical Center
Long Beach, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Tibotec Therapeutics - Division of Ortho Biotech Products, Lp
Marysville, California, United States
- Memorial Medical Center
Modesto, California, United States
- El Camino Hospital Cancer Center
Mountain View, California, United States
- Sutter Health - Western Division Cancer Research Group
Novato, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Breast Surgeons, Incorporated
Oakland, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Larry G Strieff Md Medical Corporation
Oakland, California, United States
- Tom K Lee, Incorporated
Oakland, California, United States
- St. Joseph Hospital Regional Cancer Center - Orange
Orange, California, United States
- Desert Regional Medical Center Comprehensive Cancer Center
Palm Springs, California, United States
- Valley Medical Oncology Consultants - Pleasanton
Pleasanton, California, United States
- Sutter Cancer Center at Roseville Medical Center
Roseville, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Doctors Medical Center - San Pablo Campus
San Pablo, California, United States
- Sutter Solano Medical Center
Vallejo, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2003
- Primary completion
- 31 Jan 2015
- Completion
- 31 Jan 2027
- Last update posted
- 31 Jul 2025
- Registered enrollment
- 3,294
- Registry id
- NCT00070564
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.